| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/08/2003 | EP1272516A2 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 01/08/2003 | EP1272515A2 Immunoregulator |
| 01/08/2003 | EP1272514A1 Dna encoding human vanilloid receptor vr3 |
| 01/08/2003 | EP1272513A2 Neurogenic compositions and methods |
| 01/08/2003 | EP1272512A2 Immunokine composition and method |
| 01/08/2003 | EP1272511A2 Molecules associated with human reproduction |
| 01/08/2003 | EP1272510A2 Pharmacologically active antiviral peptides and methods of their use |
| 01/08/2003 | EP1272508A2 Methods for producing recombinant proteins |
| 01/08/2003 | EP1272506A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/08/2003 | EP1272503A1 DNA MOLECULES ENCODING L-GLUTAMATE-GATED CHLORIDE CHANNELS FROM i RHIPICEPHALUS SANGUINEUS /i |
| 01/08/2003 | EP1272502A2 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses |
| 01/08/2003 | EP1272215A2 Pharmaceutical preparations comprising modified peptides |
| 01/08/2003 | EP1272212A2 Migraine and vasodilation treatment |
| 01/08/2003 | EP1272210A1 Chimeric nontoxic mutants of enterotoxins as mucosal adjuvants for cell-mediated or humoral immunity |
| 01/08/2003 | EP1272209A1 Use of crf receptor agonists for the treatment or prophylaxis of diseases, for example neurodegenerative diseases |
| 01/08/2003 | EP1272206A1 Non-mammalian gnrh analogs and uses thereof in tumor cell growth regulation and cancer therapy |
| 01/08/2003 | EP1272205A1 Sialoadhesin factor-2 antibodies |
| 01/08/2003 | EP1218407A4 Uses of kappa-conotoxin pviia |
| 01/08/2003 | EP1140975A4 Stable subtilin and methods of manufacture |
| 01/08/2003 | EP1012175B1 A peptide with an affinity for clotting factor viii |
| 01/08/2003 | EP1005358B1 Use of a neurturin protein product for preventing and treating hearing loss |
| 01/08/2003 | EP0996727B1 Gene conferring obese phenotype |
| 01/08/2003 | EP0974111B1 Apparatus and method for automated protein design |
| 01/08/2003 | EP0929579B1 Monoclonal antibodies against a human act and serine protease complex |
| 01/08/2003 | EP0817646B1 Methods of treating inflammation and compositions therefor |
| 01/08/2003 | EP0728194B1 In situ modification and manipulation of stem cells of the central nervous system |
| 01/08/2003 | EP0607309B1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 01/08/2003 | CN1390262A Transgenic plants exhibiting resistance to a broad spectrum of pathogens |
| 01/08/2003 | CN1390259A Lepidopteran-active bacillus thuringiensis-endotoxin compositions and methods of use |
| 01/08/2003 | CN1390257A Transfer compounds, the production and the use thereof |
| 01/08/2003 | CN1390256A Novel protein and DNA thereof |
| 01/08/2003 | CN1390255A Use of disease-associated gene |
| 01/08/2003 | CN1390233A Antitumor antibodies, proteins, and uses thereof |
| 01/08/2003 | CN1390231A Metal-binding compounds and uses thereof |
| 01/08/2003 | CN1390140A Method for linking molecular substances |
| 01/08/2003 | CN1390136A Vaccine against nepatitis B virus and human papilloma virus |
| 01/08/2003 | CN1389471A Fast and effective extraction method of plant insuline |
| 01/08/2003 | CN1389470A Stabilizer for recombinant alpha-interferon liquid |
| 01/08/2003 | CN1098103C Pharmaceutical use of sympathetic human white-cell interferon |
| 01/08/2003 | CA2415458A1 Two coloured fluorimetric protease assay |
| 01/07/2003 | US6504085 A method for extraction of heterologous protein from plant seed comprises extracting the germ portion of the seed and extracting and purifying the protein from the germ. Enhanced expression in the germ is provided, and allows for improved |
| 01/07/2003 | US6504084 Maize NPR1 polynucleotides and methods of use |
| 01/07/2003 | US6504083 Maize Gos-2 promoters |
| 01/07/2003 | US6504082 Ecdysone receptors and methods for their use |
| 01/07/2003 | US6504080 Transgenic animal model for neurodegenerative disorders |
| 01/07/2003 | US6504023 DNA encoding type II IL-1 receptors |
| 01/07/2003 | US6504022 Human bad polypeptides, encoding nucleic acids and methods of use |
| 01/07/2003 | US6504020 Isolated nucleic acids comprising Listeria dal and dat genes |
| 01/07/2003 | US6504014 Tissue specific prodrug |
| 01/07/2003 | US6504011 Recombinantly produced serum albumin is purified in a series of steps, optionally by incubation with an anion-exchange adsorbent, followed by affinity chromatography employing a hydrophobic solid phase and using a water-soluble lipid anion |
| 01/07/2003 | US6504010 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/07/2003 | US6504009 Transcriptional regulator |
| 01/07/2003 | US6504008 Cell based signal generation |
| 01/07/2003 | US6504007 GDNF receptor |
| 01/07/2003 | US6504006 Detecting and measuring the proteolytic activity of botulium type A neurotoxin in an assay are described. Detection is based on an increase in fluorescence due to hydrolysis of these internally quenched fluorescent peptide substrates by |
| 01/07/2003 | US6503888 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/07/2003 | US6503886 Gene delivery; polypeptide conjugated to fibroblast growth factor fused to nucleic acid |
| 01/07/2003 | US6503881 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 01/07/2003 | US6503752 Lymphotropic agents and vectors |
| 01/07/2003 | US6503748 Endogenous ketogulonigenium plasmid |
| 01/07/2003 | US6503747 Serotype-specific probes for Listeria monocytogenes |
| 01/07/2003 | US6503743 Isolated nucleic acid encoding a human lactate dehydrogenase and uses thereof |
| 01/07/2003 | US6503735 Polynucleotides encoding chemokine β-15 |
| 01/07/2003 | US6503734 An Isolated nucleic acid encoding the CYTb5 protein (SEQ. ID. NO. 2). An isolated CYTb5 protein comprising the amino acid sequence An expression vector comprising a nucleic acid encoding the CYTb5 protein and process of forming such |
| 01/07/2003 | US6503733 Polynucleotides which identify and encode NANCH. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NANCH and a method for producing NANCH. Agonists, antibodies |
| 01/07/2003 | US6503732 An infectious modified Tobacco Mosaic Virus (TMV) virion comprising a coat protein (CP) or a movement protein (MP) gene is replaced with a nuclear inclusion protease (NIa) expression cassette for the expression of a heterologous |
| 01/07/2003 | US6503731 Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII for binding cells |
| 01/07/2003 | US6503730 Nucleic acids encoding a cysteine rich protein |
| 01/07/2003 | US6503729 Selected polynucleotide and polypeptide sequences of the methanogenic archaeon, methanococcus jannashii |
| 01/07/2003 | US6503728 A nucleic acid comprising a nucleic acid sequence encoding pantropic hNT3 or hNGF having an alanine residue substituted at a position corresponding to D15 in hNT3 or D16 in hNGF, wherein the alanine substitution imparts trkB-binding such |
| 01/07/2003 | US6503708 Microtubule-associated protein |
| 01/07/2003 | US6503707 Method for genetic typing |
| 01/07/2003 | US6503706 The invention addresses DNA-protein-complexes, proteins, DNA sequences and antibodies that are suitable for the detection of cells with an unlimited proliferation and tumor-formation potential. The invention further addresses methods for |
| 01/07/2003 | US6503703 Identification of host cell proteins that interact with viral proteins required for virus replication, and high throughput assays to identify compounds that interfere with the specific interaction between the viral and host cell protein. |
| 01/07/2003 | US6503540 Cloning and characterization of bves, a novel gene expressed in heart and uses thereof |
| 01/07/2003 | US6503514 Attenuated strains of mycobacteria |
| 01/07/2003 | US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 01/07/2003 | US6503511 Derivatives of choline binding proteins for vaccines |
| 01/07/2003 | US6503510 As therapeutic agents for T cell tumors or B cell tumors (excluding myeloma) |
| 01/07/2003 | US6503502 Isolated DNA molecule encoding tumor suppressor inhibited pathway 2 consisting of nucleotide sequence ID 10; inhibiting tumor growth; inducing apoptosis |
| 01/07/2003 | US6503501 Targetable vector particles |
| 01/07/2003 | US6503500 Biocontrol agent containing an endotoxin gene |
| 01/07/2003 | US6503498 Apolipoprotein A-1 adenovirus vector compositions and methods |
| 01/07/2003 | US6503184 Human tumor necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2 |
| 01/07/2003 | CA2363780C Radiolabeled compounds for thrombus imaging |
| 01/07/2003 | CA2239753C Novel semaphorin z and gene encoding the same |
| 01/07/2003 | CA2220923C Process of high purity albumin production |
| 01/07/2003 | CA2190373C Yeast strains |
| 01/07/2003 | CA2113363C Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 01/07/2003 | CA2104598C Methods for selection of recombinant host cells expressing high levels of a desired protein |
| 01/07/2003 | CA2100167C Description process of the antibody (ab) repertoires and of the t-cell receptors (tcr) of an individual's immune system |
| 01/07/2003 | CA2089666C Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/07/2003 | CA2076307C Orally-active elastase inhibitors |
| 01/07/2003 | CA2069154C Polypeptides |
| 01/07/2003 | CA2055441C Her2 extracellular domain |
| 01/07/2003 | CA1341415C Targeted multifunctional proteins |
| 01/06/2003 | CA2392549A1 Acetyl-coa carboxylase subunits |
| 01/03/2003 | WO2003001249A2 Modulating photoreactivity in a cell |
| 01/03/2003 | WO2003001212A2 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | WO2003001204A2 Type 1 diabetes diagnostics and therapeutics |